DIFFUSE ASTROCYTOMA, IDH-MUTANT
Clinical trials for DIFFUSE ASTROCYTOMA, IDH-MUTANT explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE ASTROCYTOMA, IDH-MUTANT trials appear
Sign up with your email to follow new studies for DIFFUSE ASTROCYTOMA, IDH-MUTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial tests if proton therapy can spare brain tissue without hurting survival
Disease control Recruiting nowThis study compares two types of radiation therapy for people with slow-growing brain tumors (IDH-mutated gliomas). Proton therapy aims to better protect healthy brain tissue than standard photon therapy, but it's unclear if it's as effective at controlling the tumor. The trial w…
Matched conditions: DIFFUSE ASTROCYTOMA, IDH-MUTANT
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 16, 2026 22:28 UTC
-
New pill shows promise for Hard-to-Treat brain cancers
Disease control Recruiting nowThis study tests an experimental oral drug called NEO212 in people with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control the disease. About 134 adults will take part across t…
Matched conditions: DIFFUSE ASTROCYTOMA, IDH-MUTANT
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC